Vascular degeneration in Parkinson’s disease
Objective: To determine the role vascular degeneration in human Parkinson's disease (PD). Background: We have previously reported endothelial degeneration in the PD. Current study examined…Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
Objective: To explore the potential use of alpha-synuclein (α-syn) species as candidate biomarkers for Parkinson's disease (PD). Background: Despite decades of intensive research, to date,…Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease
Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetylcholinesterase and monoamine oxidase, membrane…Physical training prevents depressive-like behavior and bdnf decrease in an animal model of Parkinson’s disease
Objective: The aim of this study was to investigate the effects of two types of physical training on depressive-like behavior and pro-BDNF, BDNF and its…Can hospital admissions predict mortality in Parkinson’s?
Objective: Profile patients with Parkinson's who experience inpatient care. Assess the impact of admissions to hospital and evaluate readmissions and mortality rates. Background: People with…Assessment and connection to care: The vital role of the social worker in an interdisciplinary home visit program for advanced Parkinson’s disease patients
Objective: 1) To describe the role of social workers in managing the care coordination of homebound patients with advanced Parkinson's disease (PD); 2) to demonstrate…Cellular senescence induced by paraquat drives neuropathology associated with Parkinson’s disease
Objective: To understand the role of cellular senescence in brain aging and neurodegeneration in Parkinson's disease models. Background: Although cellular senescence has been causally linked…Medication errors: The role of the nurse in an interdisciplinary home visit program for advanced Parkinson’s disease patients
Objective: To examine the number and types of medication errors detected by a registered nurse during interdisciplinary home visits for patients with advanced Parkinson's disease…Pathophysiological mechanisms of bone mass loss for osteoporosis prevalence in Parkinson’s disease
Objective: Quantify the impact of osteoporosis in Parkinson's disease to know factors that caused bone loss. Background: Parkinson´s disease (PD) and osteoporosis are two conditions…Dyadic decision making & decisional satisfaction in advanced Parkinson’s disease
Objective: To assess (1) the types of healthcare and life preferences decisions the family dyad is making in advanced stages of Parkinson's disease (PD) and…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.